Illumina, Inc. (NASDAQ: ILMN) Stock Competitors & Peer Comparison
See ILMN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ILMN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ILMN | $228.00 | +9.51% | 33.6B | 44.19 | $5.03 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.69% |
| TMO | $647.89 | +5.67% | 238.4B | 27.70 | $23.16 | +0.29% |
| DHR | $209.36 | +3.01% | 147.1B | 26.23 | $7.98 | +0.69% |
| NTRA | $349.44 | +2.24% | 50.2B | -265.74 | -$1.32 | N/A |
| IQV | $270.94 | +1.98% | 44.4B | 22.22 | $12.13 | N/A |
| A | $153.58 | +4.62% | 42.4B | 25.85 | $5.81 | +0.67% |
| IDXX | $519.83 | +2.02% | 40.3B | 35.92 | $14.22 | N/A |
| WAT | $420.59 | +2.58% | 31.2B | 30.49 | $13.68 | N/A |
| DGX | $246.65 | +3.68% | 27.3B | 24.39 | $10.14 | +1.34% |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
ILMN vs DHR-PB Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, ILMN's ROE is +0.31%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, ILMN is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
ILMN vs TMO Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, TMO has a market cap of 238.4B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while TMO trades at $647.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas TMO's P/E ratio is 27.70. In terms of profitability, ILMN's ROE is +0.31%, compared to TMO's ROE of +0.13%. Regarding short-term risk, ILMN is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
ILMN vs DHR Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, DHR has a market cap of 147.1B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while DHR trades at $209.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas DHR's P/E ratio is 26.23. In terms of profitability, ILMN's ROE is +0.31%, compared to DHR's ROE of +0.08%. Regarding short-term risk, ILMN is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
ILMN vs NTRA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NTRA has a market cap of 50.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NTRA trades at $349.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NTRA's P/E ratio is -265.74. In terms of profitability, ILMN's ROE is +0.31%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, ILMN is more volatile compared to NTRA. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check NTRA's competition here
IQVIA Holdings Inc. (NYSE: IQV)
ILMN vs IQV Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, IQV has a market cap of 44.4B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while IQV trades at $270.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas IQV's P/E ratio is 22.22. In terms of profitability, ILMN's ROE is +0.31%, compared to IQV's ROE of +0.22%. Regarding short-term risk, ILMN is more volatile compared to IQV. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check IQV's competition here
Agilent Technologies, Inc. (NYSE: A)
ILMN vs A Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, A has a market cap of 42.4B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while A trades at $153.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas A's P/E ratio is 25.85. In terms of profitability, ILMN's ROE is +0.31%, compared to A's ROE of +0.20%. Regarding short-term risk, ILMN is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check A's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
ILMN vs IDXX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, IDXX has a market cap of 40.3B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while IDXX trades at $519.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas IDXX's P/E ratio is 35.92. In terms of profitability, ILMN's ROE is +0.31%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, ILMN is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check IDXX's competition here
Waters Corporation (NYSE: WAT)
ILMN vs WAT Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, WAT has a market cap of 31.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while WAT trades at $420.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas WAT's P/E ratio is 30.49. In terms of profitability, ILMN's ROE is +0.31%, compared to WAT's ROE of +0.02%. Regarding short-term risk, ILMN is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check WAT's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
ILMN vs DGX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, DGX has a market cap of 27.3B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while DGX trades at $246.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas DGX's P/E ratio is 24.39. In terms of profitability, ILMN's ROE is +0.31%, compared to DGX's ROE of +0.14%. Regarding short-term risk, ILMN is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check DGX's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
ILMN vs MTD Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MTD has a market cap of 26.9B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MTD trades at $1,376.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MTD's P/E ratio is 30.58. In terms of profitability, ILMN's ROE is +0.31%, compared to MTD's ROE of -12.00%. Regarding short-term risk, ILMN is more volatile compared to MTD. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check MTD's competition here
Labcorp Holdings Inc. (NYSE: LH)
ILMN vs LH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, LH has a market cap of 25.9B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while LH trades at $324.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas LH's P/E ratio is 18.72. In terms of profitability, ILMN's ROE is +0.31%, compared to LH's ROE of +0.12%. Regarding short-term risk, ILMN is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check LH's competition here
Guardant Health, Inc. (NASDAQ: GH)
ILMN vs GH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, GH has a market cap of 23.6B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while GH trades at $176.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas GH's P/E ratio is -50.33. In terms of profitability, ILMN's ROE is +0.31%, compared to GH's ROE of +2.11%. Regarding short-term risk, ILMN is more volatile compared to GH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
ILMN vs EXAS Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas EXAS's P/E ratio is -95.37. In terms of profitability, ILMN's ROE is +0.31%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, ILMN is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check EXAS's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
ILMN vs MEDP Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MEDP has a market cap of 17.3B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MEDP trades at $618.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MEDP's P/E ratio is 36.37. In terms of profitability, ILMN's ROE is +0.31%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, ILMN is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check MEDP's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
ILMN vs ILMNV Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ILMNV's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to ILMNV's ROE of N/A. Regarding short-term risk, ILMN is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check ILMNV's competition here
Revvity, Inc. (NYSE: RVTY)
ILMN vs RVTY Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, RVTY has a market cap of 15.6B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while RVTY trades at $145.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas RVTY's P/E ratio is 26.19. In terms of profitability, ILMN's ROE is +0.31%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, ILMN is more volatile compared to RVTY. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check RVTY's competition here
PerkinElmer, Inc. (NYSE: PKI)
ILMN vs PKI Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PKI's P/E ratio is 41.45. In terms of profitability, ILMN's ROE is +0.31%, compared to PKI's ROE of +0.03%. Regarding short-term risk, ILMN is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check PKI's competition here
ICON Public Limited Company (NASDAQ: ICLR)
ILMN vs ICLR Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ICLR has a market cap of 13.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ICLR trades at $174.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ICLR's P/E ratio is 14.07. In terms of profitability, ILMN's ROE is +0.31%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, ILMN is more volatile compared to ICLR. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check ICLR's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
ILMN vs CRL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CRL has a market cap of 13.1B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CRL trades at $279.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CRL's P/E ratio is 27.53. In terms of profitability, ILMN's ROE is +0.31%, compared to CRL's ROE of -0.08%. Regarding short-term risk, ILMN is more volatile compared to CRL. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CRL's competition here
Qiagen N.V. (NYSE: QGEN)
ILMN vs QGEN Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, QGEN has a market cap of 8.8B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while QGEN trades at $43.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas QGEN's P/E ratio is 17.55. In terms of profitability, ILMN's ROE is +0.31%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, ILMN is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check QGEN's competition here
RadNet, Inc. (NASDAQ: RDNT)
ILMN vs RDNT Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, RDNT has a market cap of 6.1B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while RDNT trades at $77.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas RDNT's P/E ratio is 167.65. In terms of profitability, ILMN's ROE is +0.31%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, ILMN is more volatile compared to RDNT. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
ILMN vs SHC Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, SHC has a market cap of 5.4B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while SHC trades at $19.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas SHC's P/E ratio is 19.77. In terms of profitability, ILMN's ROE is +0.31%, compared to SHC's ROE of +0.27%. Regarding short-term risk, ILMN is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check SHC's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
ILMN vs BLLN Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BLLN has a market cap of 4.8B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BLLN trades at $105.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BLLN's P/E ratio is 148.96. In terms of profitability, ILMN's ROE is +0.31%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, ILMN is more volatile compared to BLLN. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check BLLN's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
ILMN vs SYNH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas SYNH's P/E ratio is 61.40. In terms of profitability, ILMN's ROE is +0.31%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, ILMN is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check SYNH's competition here
GRAIL Inc. (NASDAQ: GRAL)
ILMN vs GRAL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, GRAL has a market cap of 3.3B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while GRAL trades at $76.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas GRAL's P/E ratio is -7.78. In terms of profitability, ILMN's ROE is +0.31%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, ILMN is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check GRAL's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
ILMN vs OLK Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas OLK's P/E ratio is -96.59. In terms of profitability, ILMN's ROE is +0.31%, compared to OLK's ROE of -0.07%. Regarding short-term risk, ILMN is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check OLK's competition here
Veracyte, Inc. (NASDAQ: VCYT)
ILMN vs VCYT Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, VCYT has a market cap of 3.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while VCYT trades at $40.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas VCYT's P/E ratio is 20.07. In terms of profitability, ILMN's ROE is +0.31%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, ILMN is more volatile compared to VCYT. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check VCYT's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
ILMN vs WGS Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, WGS has a market cap of 2.8B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while WGS trades at $98.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas WGS's P/E ratio is 262.89. In terms of profitability, ILMN's ROE is +0.31%, compared to WGS's ROE of -0.39%. Regarding short-term risk, ILMN is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check WGS's competition here
CareDx, Inc (NASDAQ: CDNA)
ILMN vs CDNA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CDNA has a market cap of 2.7B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CDNA trades at $54.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CDNA's P/E ratio is 62.67. In terms of profitability, ILMN's ROE is +0.31%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, ILMN is more volatile compared to CDNA. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
ILMN vs PSNL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PSNL trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PSNL's P/E ratio is -14.77. In terms of profitability, ILMN's ROE is +0.31%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, ILMN is more volatile compared to PSNL. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
ILMN vs OPK Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, OPK has a market cap of 1.2B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while OPK trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas OPK's P/E ratio is -5.81. In terms of profitability, ILMN's ROE is +0.31%, compared to OPK's ROE of -0.06%. Regarding short-term risk, ILMN is more volatile compared to OPK. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
ILMN vs CSTL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CSTL has a market cap of 1.1B. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CSTL trades at $35.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CSTL's P/E ratio is -53.79. In terms of profitability, ILMN's ROE is +0.31%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, ILMN is more volatile compared to CSTL. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
ILMN vs FLGT Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, FLGT has a market cap of 604.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while FLGT trades at $21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas FLGT's P/E ratio is 2128.00. In terms of profitability, ILMN's ROE is +0.31%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, ILMN is more volatile compared to FLGT. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
ILMN vs GRALV Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas GRALV's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to GRALV's ROE of N/A. Regarding short-term risk, ILMN is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check GRALV's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
ILMN vs NEO Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NEO has a market cap of 485.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NEO trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NEO's P/E ratio is 145.31. In terms of profitability, ILMN's ROE is +0.31%, compared to NEO's ROE of -0.06%. Regarding short-term risk, ILMN is more volatile compared to NEO. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check NEO's competition here
Global Cord Blood Corporation (NYSE: CO)
ILMN vs CO Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CO's P/E ratio is 5.06. In terms of profitability, ILMN's ROE is +0.31%, compared to CO's ROE of +0.11%. Regarding short-term risk, ILMN is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check CO's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
ILMN vs MYGN Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MYGN has a market cap of 366.5M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MYGN trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MYGN's P/E ratio is -29.85. In terms of profitability, ILMN's ROE is +0.31%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, ILMN is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check MYGN's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
ILMN vs FLDM Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas FLDM's P/E ratio is -4.74. In terms of profitability, ILMN's ROE is +0.31%, compared to FLDM's ROE of +0.18%. Regarding short-term risk, ILMN is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check FLDM's competition here
Prenetics Global Limited (NASDAQ: PRENW)
ILMN vs PRENW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PRENW has a market cap of 277.8M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PRENW's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to PRENW's ROE of -0.49%. Regarding short-term risk, ILMN is less volatile compared to PRENW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check PRENW's competition here
Biodesix, Inc. (NASDAQ: BDSX)
ILMN vs BDSX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BDSX has a market cap of 225.5M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BDSX trades at $28.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BDSX's P/E ratio is -8.74. In terms of profitability, ILMN's ROE is +0.31%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, ILMN is more volatile compared to BDSX. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
ILMN vs XGN Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, XGN has a market cap of 181M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while XGN trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas XGN's P/E ratio is -9.25. In terms of profitability, ILMN's ROE is +0.31%, compared to XGN's ROE of -1.22%. Regarding short-term risk, ILMN is more volatile compared to XGN. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check XGN's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
ILMN vs IMDX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, IMDX has a market cap of 129.8M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while IMDX trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas IMDX's P/E ratio is -2.70. In terms of profitability, ILMN's ROE is +0.31%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, ILMN is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
ILMN vs GTH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas GTH's P/E ratio is -1.11. In terms of profitability, ILMN's ROE is +0.31%, compared to GTH's ROE of -1.01%. Regarding short-term risk, ILMN is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
ILMN vs GENE Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas GENE's P/E ratio is -38.25. In terms of profitability, ILMN's ROE is +0.31%, compared to GENE's ROE of -1.85%. Regarding short-term risk, ILMN is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check GENE's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
ILMN vs SERA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, SERA has a market cap of 76M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while SERA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas SERA's P/E ratio is -3.06. In terms of profitability, ILMN's ROE is +0.31%, compared to SERA's ROE of -0.47%. Regarding short-term risk, ILMN is more volatile compared to SERA. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check SERA's competition here
Precipio, Inc. (NASDAQ: PRPO)
ILMN vs PRPO Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PRPO has a market cap of 48.6M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PRPO trades at $25.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PRPO's P/E ratio is -104.77. In terms of profitability, ILMN's ROE is +0.31%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, ILMN is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check PRPO's competition here
MDxHealth S.A. (NASDAQ: MDXH)
ILMN vs MDXH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MDXH has a market cap of 34.6M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MDXH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MDXH's P/E ratio is -1.77. In terms of profitability, ILMN's ROE is +0.31%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, ILMN is more volatile compared to MDXH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check MDXH's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
ILMN vs QUCY Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, QUCY has a market cap of 30.5M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while QUCY trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas QUCY's P/E ratio is -0.06. In terms of profitability, ILMN's ROE is +0.31%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, ILMN is more volatile compared to QUCY. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check QUCY's competition here
Akumin Inc. (NASDAQ: AKU)
ILMN vs AKU Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas AKU's P/E ratio is -0.13. In terms of profitability, ILMN's ROE is +0.31%, compared to AKU's ROE of -5.32%. Regarding short-term risk, ILMN is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check AKU's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
ILMN vs CEMI Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CEMI's P/E ratio is -0.63. In terms of profitability, ILMN's ROE is +0.31%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, ILMN is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
ILMN vs ENZ Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ENZ's P/E ratio is -2.24. In terms of profitability, ILMN's ROE is +0.31%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, ILMN is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
ILMN vs PMD Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PMD's P/E ratio is -5.24. In terms of profitability, ILMN's ROE is +0.31%, compared to PMD's ROE of -0.32%. Regarding short-term risk, ILMN is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
ILMN vs ME Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ME's P/E ratio is -0.03. In terms of profitability, ILMN's ROE is +0.31%, compared to ME's ROE of -42.03%. Regarding short-term risk, ILMN is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
ILMN vs MYNZ Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, ILMN's ROE is +0.31%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, ILMN is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check MYNZ's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
ILMN vs BNR Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BNR has a market cap of 12.2M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BNR trades at $13.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BNR's P/E ratio is -13.29. In terms of profitability, ILMN's ROE is +0.31%, compared to BNR's ROE of -0.13%. Regarding short-term risk, ILMN is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check BNR's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
ILMN vs ADVB Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ADVB has a market cap of 11.2M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ADVB trades at $8.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ADVB's P/E ratio is -73.45. In terms of profitability, ILMN's ROE is +0.31%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, ILMN is more volatile compared to ADVB. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check ADVB's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
ILMN vs CHEK Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CHEK's P/E ratio is -0.43. In terms of profitability, ILMN's ROE is +0.31%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, ILMN is more volatile compared to CHEK. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
ILMN vs CNTG Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CNTG's P/E ratio is -0.23. In terms of profitability, ILMN's ROE is +0.31%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, ILMN is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check CNTG's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
ILMN vs NDRA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NDRA has a market cap of 7.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NDRA trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NDRA's P/E ratio is -0.73. In terms of profitability, ILMN's ROE is +0.31%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, ILMN is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
ILMN vs APDN Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas APDN's P/E ratio is -0.10. In terms of profitability, ILMN's ROE is +0.31%, compared to APDN's ROE of -7.23%. Regarding short-term risk, ILMN is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
ILMN vs NVTA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NVTA's P/E ratio is -0.00. In terms of profitability, ILMN's ROE is +0.31%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, ILMN is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDXW)
ILMN vs LMDXW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, ILMN's ROE is +0.31%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, ILMN is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check LMDXW's competition here
LumiraDx Limited (NASDAQ: LMDX)
ILMN vs LMDX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas LMDX's P/E ratio is -0.01. In terms of profitability, ILMN's ROE is +0.31%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, ILMN is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check LMDX's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
ILMN vs BIAFW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BIAFW has a market cap of 4.6M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BIAFW trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BIAFW's P/E ratio is 0.49. In terms of profitability, ILMN's ROE is +0.31%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, ILMN is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check BIAFW's competition here
DermTech, Inc. (NASDAQ: DMTK)
ILMN vs DMTK Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas DMTK's P/E ratio is -0.04. In terms of profitability, ILMN's ROE is +0.31%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, ILMN is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
ILMN vs NOTV Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NOTV's P/E ratio is -0.03. In terms of profitability, ILMN's ROE is +0.31%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, ILMN is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check NOTV's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
ILMN vs BIAF Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BIAF has a market cap of 2.6M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BIAF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BIAF's P/E ratio is -0.73. In terms of profitability, ILMN's ROE is +0.31%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, ILMN is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
ILMN vs SQL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas SQL's P/E ratio is -0.40. In terms of profitability, ILMN's ROE is +0.31%, compared to SQL's ROE of -30.46%. Regarding short-term risk, ILMN is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
ILMN vs AWH Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas AWH's P/E ratio is -0.09. In terms of profitability, ILMN's ROE is +0.31%, compared to AWH's ROE of +1.62%. Regarding short-term risk, ILMN is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check AWH's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
ILMN vs HTGM Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas HTGM's P/E ratio is -0.03. In terms of profitability, ILMN's ROE is +0.31%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, ILMN is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
ILMN vs BIOC Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BIOC's P/E ratio is -0.01. In terms of profitability, ILMN's ROE is +0.31%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, ILMN is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
ILMN vs ISPC Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, ISPC has a market cap of 184.7K. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while ISPC trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas ISPC's P/E ratio is -0.04. In terms of profitability, ILMN's ROE is +0.31%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, ILMN is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
ILMN vs SQLLW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, ILMN's ROE is +0.31%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, ILMN is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check SQLLW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
ILMN vs WGSWW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, ILMN's ROE is +0.31%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, ILMN is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check WGSWW's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
ILMN vs MEUSW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas MEUSW's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, ILMN is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check MEUSW's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
ILMN vs NDRAW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas NDRAW's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, ILMN is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check NDRAW's competition here
Danaher Corporation (NYSE: DHR-PA)
ILMN vs DHR-PA Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, ILMN's ROE is +0.31%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, ILMN is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check DHR-PA's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
ILMN vs PRXL Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas PRXL's P/E ratio is 42.97. In terms of profitability, ILMN's ROE is +0.31%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, ILMN is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check PRXL's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
ILMN vs OCDX Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas OCDX's P/E ratio is -42.28. In terms of profitability, ILMN's ROE is +0.31%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, ILMN is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for ILMN.Check OCDX's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
ILMN vs BNGOW Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas BNGOW's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, ILMN is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check BNGOW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
ILMN vs CHEKZ Comparison September 2026
Illumina, Inc. (NASDAQ: ILMN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ILMN stands at 33.6B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, ILMN is priced at $228.00 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ILMN currently has a P/E ratio of 44.19, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, ILMN's ROE is +0.31%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, ILMN is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for ILMN.Check CHEKZ's competition here